focuses on the health and life of a person with a history of cancer beyond the acute diagnosis and treatment phase. It seeks to both prevent and control adverse cancer diagnosis and treatment-related outcomes such as late effects of treatment, second cancers, and poor quality of life, to provide a knowledge base regarding optimal follow-up care and surveillance of cancers, and to optimize health after cancer treatment (from OCS).


—a set of symptoms or conditions that occur together and suggest the presence of a certain disease or an increased chance of developing the disease.

third-party payors

—entities that pay for health care, but are not the direct recipient of care. Includes insurers, employers, and the local, state, and federal governments (through Medicare, Medicaid, and other programs).


—the formation or presence of a blood clot inside a blood vessel.


—a measure of the degree to which something is toxic or poisonous.


—the replacement of tissue with tissue from the person’s own body or from another person.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement